INIO Reports Q3 as Shorts Retreat and Analysts Hold Bullish Ratings

INIO delivered its Q3 results on October 28, and the immediate data story is a sharp reversal in short positioning against a backdrop where Wall Street's conviction, while still positive, has been visibly trimmed.

The most striking move in the lending market this week is how quickly shorts unwound ahead of the print. Borrowed shares fell from a monthly peak near 22 million in mid-October to around 19.6 million by October 27, a drop of roughly 11% in just a few sessions. Over the past month, however, the picture is less clean: short interest is still up roughly 28% from late September levels, when fewer than 17 million shares were short. The borrow market itself is loose. Availability is running at roughly 397%, meaning nearly four shares remain available to borrow for every one already lent out. That is well above the 52-week tightest point of 291%, and the cost to borrow has fallen sharply, down more than 59% over the past month to 0.66%. Shorts are not under pressure in the lending market, and new positions are cheap to put on.

Options positioning tells a different story to the short interest retreat. The put/call ratio at 4.40 is structurally elevated, well above the broad market but in line with this stock's own recent norm, where the 20-day average is 4.74. The ratio is actually running a little below that average right now, about 0.7 standard deviations below the mean, and has eased from the 52-week high of 5.90 reached on October 19. That suggests the peak of defensive hedging in the options market may have passed just as the print arrived.

Analyst sentiment captures the central tension for this stock well. Three firms trimmed targets in the weeks leading up to earnings: JP Morgan's Mark Strouse cut to $33 from $40, Morgan Stanley's David Arcaro moved to $40 from $47, and Citigroup lowered its Neutral target to $22 from $30. All three maintained their existing ratings. The consensus price target sits at $32.80, against a current price of $16.98. That gap is substantial. It partly reflects how far the stock has fallen from where it was trading when coverage was initiated in late June, with initiation targets ranging from $39 to $48. Advent International holds roughly 44.6% of shares reported in filings, a dominant position that concentrates influence but also limits the stock's float. The ORTEX short score is at 46.8, broadly neutral, eased from 50.5 earlier in the week as short interest retreated.

The valuation has compressed sharply. The price-to-book multiple has fallen by roughly 2.3 points over the past month to 13.4x, and the PE has dropped more than 4 points over the same period to 22.6x. EV/EBITDA is relatively stable at 14.3x, with only modest movement over 30 days. Those moves reflect both the 11% price decline and any underlying earnings-estimate drift. The stock regained 4.6% over the past week and added 2.1% on October 27, the day before the print, which suggests some positioning adjustment in the final session.

What to watch from here is how the analyst community responds to the actual Q3 numbers: whether the firms that maintained Overweight ratings through a run of target cuts now hold their line, revise further, or begin to close the distance between targets and where the stock is actually trading.